Jan 05, 2026 // Heading into 2026, the geopolitical and global governance short–term outlooks look perilous. Yet many ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for ...
Experienced Industry Leader with More than Two Decades of Global Commercialization and Marketing ExpertiseSAN DIEGO, Jan. 7, 2026 /PRNewswire/ -- Viking ...
A commonly discussed concept in CitrusBurn reviews and consumer feedback is the idea of "clean energy.” This term is often ...
1dOpinion
Analysis: The iron law doctrine; Trump signals a new American order built on power, not permission
In the wake of the U.S. operation that seized Venezuelan President Nicolás Maduro, Deputy White House Chief of Staff Stephen ...
These questions form the basis of our conversation with Oleh Shamshur, Ambassador Extraordinary and Plenipotentiary of ...
Over the last 12 months, Beyond Meat ( BYND +2.46%) stock has cratered by around 77%. With a market cap of $400 million and a ...
The Chosun Ilbo on MSN
Prime Minister Kim Unveils Ministry of Planning and Budget Signboard
Prime Minister Kim Unveils Ministry of Planning and Budget Signboard New ministry split from Economy and Finance to handle ...
Experienced Industry Leader with More than Two Decades of Global Commercialization and Marketing Expertise SAN DIEGO, Jan. 7, 2026 /PRNewswire/ -- Viking Therapeutics ...
7d
Merck: A Pharma Giant Trading At A Decade-Low Valuation While Executing Its Post-Keytruda Playbook
Merck (MRK) looks undervalued amid 2028 Keytruda patent fears—strong Q3 results, pipeline wins, and 12x P/E suggest upside.
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the “Company” or “PharmaTher”) today announced that CEO Fabio Chianelli has published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback